Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etidronate for Fahr's disease or Fahr's syndrome
ISRCTN10492452Phase 2Recruiting
- Sponsor
- University Medical Center Utrecht
- Start
- Apr 2023
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial in idiopathic basal ganglia calcification (PFBC) comparing Etidronate with Placebo (2 arms). Primary endpoints: Overall cognitive functioning at 12 months, Memory at 12 months and 3 more. Started Apr 2023; status: recruiting.
02
Drugs
etidronate
03
Conditions
idiopathic basal ganglia calcification (PFBC)
Beyond the preview
Go deeper on ISRCTN10492452.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN10492452.